Your browser doesn't support javascript.
loading
Fc receptor-like 1 intrinsically recruits c-Abl to enhance B cell activation and function.
Zhao, Xingwang; Xie, Hengyi; Zhao, Meng; Ahsan, Asma; Li, Xinxin; Wang, Fei; Yi, Junyang; Yang, Zhiyong; Wu, Chuan; Raman, Indu; Li, Quan-Zhen; Kim, Tae Jin; Liu, Wanli.
Afiliação
  • Zhao X; MOE Key Laboratory of Protein Sciences, Center for Life Sciences, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, School of Life Sciences, Beijing Key Lab for Immunological Research on Chronic Diseases, Institute for Immunology, Tsinghua University, Beijing 100084
  • Xie H; MOE Key Laboratory of Protein Sciences, Center for Life Sciences, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, School of Life Sciences, Beijing Key Lab for Immunological Research on Chronic Diseases, Institute for Immunology, Tsinghua University, Beijing 100084
  • Zhao M; MOE Key Laboratory of Protein Sciences, Center for Life Sciences, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, School of Life Sciences, Beijing Key Lab for Immunological Research on Chronic Diseases, Institute for Immunology, Tsinghua University, Beijing 100084
  • Ahsan A; Biochemistry and Structural Biology Lab, Department of Biology, Syed Babar Ali School of Science and Engineering, Lahore University of Management of Sciences (LUMS) Lahore, Pakistan.
  • Li X; MOE Key Laboratory of Protein Sciences, Center for Life Sciences, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, School of Life Sciences, Beijing Key Lab for Immunological Research on Chronic Diseases, Institute for Immunology, Tsinghua University, Beijing 100084
  • Wang F; Natural Products Research Center, Chengdu Institute of Biology, Chinese Academy of Science, Chengdu 610041, China.
  • Yi J; MOE Key Laboratory of Protein Sciences, Center for Life Sciences, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, School of Life Sciences, Beijing Key Lab for Immunological Research on Chronic Diseases, Institute for Immunology, Tsinghua University, Beijing 100084
  • Yang Z; Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA 94143, USA.
  • Wu C; Experimental Immunology Branch, National Cancer Institute, U.S. National Institutes of Health, Bethesda, MD 20851, USA.
  • Raman I; Department of Immunology and Internal Medicine, IIMT Microarray Core Facility, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
  • Li QZ; Department of Immunology and Internal Medicine, IIMT Microarray Core Facility, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
  • Kim TJ; Division of Immunobiology, School of Medicine, Sungkyunkwan University, 2066 Seobu-ro, Jangan-gu, Suwon 16419, Republic of Korea.
  • Liu W; MOE Key Laboratory of Protein Sciences, Center for Life Sciences, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, School of Life Sciences, Beijing Key Lab for Immunological Research on Chronic Diseases, Institute for Immunology, Tsinghua University, Beijing 100084
Sci Adv ; 5(7): eaaw0315, 2019 07.
Article em En | MEDLINE | ID: mdl-31328160

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos B / Ativação Linfocitária / Proteínas Proto-Oncogênicas c-abl / Proteínas de Membrana Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Sci Adv Ano de publicação: 2019 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos B / Ativação Linfocitária / Proteínas Proto-Oncogênicas c-abl / Proteínas de Membrana Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Sci Adv Ano de publicação: 2019 Tipo de documento: Article País de publicação: Estados Unidos